Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
47.86
-0.13 (-0.27%)
At close: Dec 5, 2025, 4:00 PM EST
47.98
+0.12 (0.25%)
After-hours: Dec 5, 2025, 7:59 PM EST
Novo Nordisk (NVO) Operating Income by Segment
History
| Date | Diabetes and Obesity Care | Rare Disease |
|---|---|---|
| Jun 30, 2025 | 21.95B | 328.26M |
| Mar 31, 2025 | 21.02B | 83.63M |
| Dec 31, 2024 | 19.93B | 96.73M |
| Sep 30, 2024 | 18.36B | 103.13M |
| Jun 30, 2024 | 17.31B | 78.63M |
| Mar 31, 2024 | 16.64B | 426.71M |
| Dec 31, 2023 | 15.54B | 460.41M |
| Sep 30, 2023 | 14.13B | 361.81M |
| Jun 30, 2023 | 12.80B | 647.94M |
| Mar 31, 2023 | 11.73B | 856.54M |
| Dec 31, 2022 | 10.51B | 1.16B |
| Sep 30, 2022 | 9.72B | 1.42B |
| Jun 30, 2022 | 8.92B | 1.44B |
| Mar 31, 2022 | 8.34B | 1.46B |
| Dec 31, 2021 | 7.73B | 1.42B |
| Sep 30, 2021 | 7.30B | 1.47B |
| Jun 30, 2021 | 6.78B | 1.60B |
| Mar 31, 2021 | 6.67B | 1.57B |
| Dec 31, 2020 | 6.82B | 1.62B |
| Sep 30, 2020 | 6.81B | 1.74B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.